In Reply
- PMID: 28894018
- PMCID: PMC5728026
- DOI: 10.1634/theoncologist.2017-0283
In Reply
Abstract
This letter responds to the letter from Tan et al., noting points of agreement and encouraging efforts to share genomic signatures and codes that will make future research faster and more effective.
Comment on
-
Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model.Oncologist. 2017 Mar;22(3):286-292. doi: 10.1634/theoncologist.2016-0078. Epub 2017 Feb 20. Oncologist. 2017. PMID: 28220024 Free PMC article.
-
The Issue of Tissue in Molecular Stratification.Oncologist. 2017 Dec;22(12):1560. doi: 10.1634/theoncologist.2017-0165. Epub 2017 Sep 11. Oncologist. 2017. PMID: 28894016 Free PMC article.
References
-
- Heng DY, Xie W, Regan MM et al. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor‐targeted agents: Results from a large, multicenter study. J Clin Oncol 2009;27:5794–5799. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
